On October 24, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted its final opinion on Iclusig® (ponatinib) following the recommendations made by the Pharmacovigilance Risk Assessment Committee (PRAC) earlier this month. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in last trading activity fell -1.68% to close at $5.87. Company weekly performance is 5.01% … Continue reading Stock Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), Sony Corp (ADR) (NYSE:SNE), SinoCoking Coal and Coke Chemical Industries (NASDAQ:SCOK), Daxor (NYSEMKT:DXR), Limoneira Company (NASDAQ:LMNR)